Physician

Shaukat Ali, M.D.

According to 2025 Medicare claims, Shaukat Ali, M.D. (NPI: 1700956844) practices internal medicine in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Mc Cracken, KY. This provider's primary affiliated billing organization is KIDNEY SPECIALISTS OF PADUCAH PLLC (NPI: 1740765957; TIN: 831141225) and primary practice location at 42003-7942. Ali is affiliated with the IRCCO (ACO ID: A2619) and The Rural Advantage LLC (ACO ID: A5257), participating under the MSSP model.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 817 traditional Medicare patients, billed 5,064 HCPCS/CPT codes, and received $273,130 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 3,619 prescription claims across 502 beneficiaries totaling $1,246,442 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 24 claims. Open Payments data shows 96 records totaling $1,680. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $407,851 to $273,130. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $355,884 to $1,246,442. For DME billing, this smaller-volume category fell sharply in recent years, from $2,313 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,038	6,350	$407,851
2016	1,226	8,469	$439,843
2017	1,091	5,174	$388,269
2018	1,165	5,069	$437,062
2019	1,187	4,750	$414,563
2020	1,146	5,787	$386,368
2021	1,089	6,079	$421,096
2022	940	5,740	$337,731
2023	807	4,400	$260,709
2024	817	5,064	$273,130

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	491	3,220	$355,884
2016	562	4,220	$314,304
2017	470	3,279	$309,180
2018	444	2,737	$756,802
2019	420	2,763	$1,076,379
2020	443	2,705	$771,193
2021	478	2,983	$420,845
2022	445	2,858	$474,891
2023	477	2,968	$934,860
2024	502	3,619	$1,246,442

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	80	$5,037
2016	N/R	97	$3,587
2017	N/R	48	$2,094
2018	N/R	109	$5,992
2019	N/R	93	$3,144
2020	N/R	31	$626
2021	N/R	57	$5,009
2022	N/R	52	$3,916
2023	N/R	11	$1,331
2024	N/R	24	$1,299

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	79	169	$283
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	118	120	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	367	644	$85
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	266	939	$63
90935	Hemodialysis procedure with physician evaluation	92	208	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	609	22,727	$417,106
Jardiance	Empagliflozin	188	7,614	$146,949
Xphozah	Tenapanor Hcl	41	1,440	$140,864
Velphoro	Sucroferric Oxyhydroxide	20	780	$84,428
Rayaldee	Calcifediol	51	1,830	$75,268

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$1,073
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	96	$1,680	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shaukat Ali, M.D.?

Tedicare shows public-source Medicare data for Shaukat Ali, M.D. (NPI 1700956844), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shaukat Ali, M.D. have ACO affiliation data?

Shaukat Ali, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and The Rural Advantage LLC (MSSP, ACO ID A5257).

What billing organization is linked to Shaukat Ali, M.D.?

Shaukat Ali, M.D. is linked to KIDNEY SPECIALISTS OF PADUCAH PLLC (billing NPI 1740765957) in the available physician profile data.

Does Shaukat Ali, M.D. have Open Payments data?

Shaukat Ali, M.D. has 96 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.